Zoledronic Acid Ameliorates the Bone Turnover Activity and Periprosthetic Bone Preservation in Cementless Total Hip Arthroplasty

• Egile Nagusiak: Allen Herng Shouh Hsu (Egilea), Chun-Hsien Yen (Egilea), Feng-Chih Kuo (Egilea), Cheng-Ta Wu (Egilea), Tsan-Wen Huang (Egilea), Juei-Tang Cheng (Egilea), Mel S. Lee (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2022-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The administration of zoledronic acid (ZA) to patients who received cementless total hip arthroplasty (THA) has been reported to reduce bone turnover markers (BTMs) and increase bone mineral density (BMD). The effects of two-dose ZA versus placebo on cementless THA patients were analyzed in this fiv...